Research

Exercise Declined in Patients with Obesity After Starting a GLP-1

Patients with obesity showed reduced physical activity after initiating GLP-1 receptor agonists, according to a recent analysis.

GLP-1 Receptor Agonists Linked to Elevated Hypotension Risk

GLP-1 receptor agonists are associated with an increased incidence of hypotensive events, particularly in patients with pre-existing cardiovascular risk factors.

Oxygen Titration Protocol Reduces Severe Hyperoxemia in ED

A structured oxygen titration protocol in the emergency department significantly reduced the incidence of severe hyperoxemia, improving patient outcomes.

Virtual Team-Based GI Care Superior to Traditional Care

A virtual team-based care model for gastrointestinal conditions demonstrated superior patient outcomes and reduced healthcare utilisation compared to traditional care.

Chemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)

Chemotherapy-free regimens for pediatric acute promyelocytic leukemia (APL) demonstrate superior efficacy and reduced toxicity compared to traditional chemotherapy.

Macrophages: Dual Role in Haematological Malignancies Explored

Macrophages exhibit a dual role in haematological malignancies, acting as both tumour suppressors and promoters, influencing disease progression and therapeutic responses.

Molecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026

EHA 2026 will review a quarter-century of molecular hematology, focusing on the integration of genomic data into targeted therapeutic strategies.

Home-Based Stimulation for Bipolar Depression Shows Mixed Efficacy

Home-based transcranial direct current stimulation (tDCS) for bipolar depression yields inconsistent results, with some studies showing modest benefits while others report no significant difference from sham.

AD Biomarkers Linked to Worse Cognition in Midlife Adults

Elevated Alzheimer's disease biomarkers in midlife adults are associated with poorer cognitive performance, indicating preclinical disease progression.

Psilocybin Effective for TRD in Real-World Trial

Psilocybin-assisted therapy (PAT) demonstrates clinical promise for treatment-resistant depression (TRD), with ongoing evaluation of its economic value.